72769-113-02 : NDC 2026 Code

72769-113-02 : Berotralstat Hydrochloride ( Orladeyo )

Additionally :

You can get information about “72769-113-02” NDC code in 72769-113-02 in HTML format

HTML | 72769-113-02 in TXT (Plain Text) format

TXT | 72769-113-02 in PDF (Portable Document Format)

PDF | 72769-113-02 in XML format

XML formats.

NDC Code : 72769-113-02 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "72769-113-02",
    "PackageDescription": "4 DOSE PACK in 1 CARTON (72769-113-02)  / 7 PACKET in 1 DOSE PACK / 18 PELLET in 1 PACKET",
    "NDC11Code": "72769-0113-02",
    "ProductNDC": "72769-113",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Orladeyo",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Berotralstat Hydrochloride",
    "DosageFormName": "PELLET",
    "RouteName": "ORAL",
    "StartMarketingDate": "20201204",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA219776",
    "LabelerName": "BioCryst Pharmaceuticals Inc.",
    "SubstanceName": "BEROTRALSTAT HYDROCHLORIDE",
    "StrengthNumber": "108",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kallikrein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Plasma Kallikrein Inhibitor [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-12-17",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20201212",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}